| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1574-6968.1998.TB13131.X |
| P698 | PubMed publication ID | 9711843 |
| P50 | author | Jesus Blazquez | Q68273789 |
| P2093 | author name string | F Baquero | |
| M I Morosini | |||
| M C Negri | |||
| B Shoichet | |||
| M R Baquero | |||
| P433 | issue | 1 | |
| P304 | page(s) | 85-90 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | FEMS Microbiology Letters | Q15756366 |
| P1476 | title | An extended-spectrum AmpC-type beta-lactamase obtained by in vitro antibiotic selection | |
| P478 | volume | 165 |
| Q37568397 | AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins |
| Q33979636 | Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei |
| Q33594641 | Biological cost of AmpC production for Salmonella enterica serotype Typhimurium |
| Q35027042 | Dissemination of SHV-12 and characterization of new AmpC-type beta-lactamase genes among clinical isolates of enterobacter species in Korea |
| Q39537397 | Heterogeneity of AmpC cephalosporinases of Hafnia alvei clinical isolates expressing inducible or constitutive ceftazidime resistance phenotypes |
| Q33945503 | Mutation frequencies and antibiotic resistance |
| Q39478020 | Mutation in Serratia marcescens AmpC beta-lactamase producing high-level resistance to ceftazidime and cefpirome |
| Q39651911 | Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 beta-lactamase confers increased MIC of cefepime |
| Q33422956 | New disturbing trend in antimicrobial resistance of gram-negative pathogens |
| Q33966850 | Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. |
| Q24535748 | Plasmid-determined AmpC-type beta-lactamases |
| Q36491987 | Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate |
| Q40622081 | Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate |
| Q27658160 | Structural Bases for Stability–Function Tradeoffs in Antibiotic Resistance |
| Q34522266 | Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase |
| Q27620652 | The complexed structure and antimicrobial activity of a non-β-lactam inhibitor of AmpC β-lactamase |
Search more.